Catalyst Wire Dossier Catalyst Wire Dossier

RELEARN Neurofeedback

· Redo-Neurosystems
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RELEARN Neurofeedback, covering 2024-02-06 to 2024-02-06. Get the full timeline:

Most recent: Clinical Trial Update: Investigating RELEARN Neurofeedback as Treatment for Chronic Musculoskeletal Pain [Phase 2, Phase 3]

See pricing